Liise-Anne Pirofski

InstitutionAlbert Einstein College of Medicine and Montefiore Medical Center
AddressBronx
New York
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 3 publications in December 2020 and April 2021 and June 2021
    All Publications
    Bar chart showing 112 publications over 20 distinct years, with a maximum of 12 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pirofski LA. Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic. Clin Infect Dis. 2021 09 15; 73(6):e1345-e1347. PMID: 33905478.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Focosi D, Franchini M, Pirofski LA, Burnouf T, Fairweather D, Joyner MJ, Casadevall A. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8). PMID: 34452459.
      Citations:    Fields:    Translation:HumansCells
    3. Casadevall A, Joyner MJ, Pirofski LA. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy. Clin Infect Dis. 2021 08 02; 73(3):e540-e542. PMID: 32805024.
      Citations: 2     Fields:    Translation:Humans
    4. Cowman K, Guo Y, Pirofski LA, Wong D, Bao H, Chen V, Hopkins U, Andrews E, Hamel J, Keller M, Bellin E, Thota R, Davis P, Rodriguez ET, Suthar P, Allen L, Rossi J, Haviland A, Orner E, Szymczak W, Shujauddin S, McCarthy J, Binder B, Pushparaj V, Bard L, Pierino VF, Alsina L, Esses D, McCaskie A, Campbell C, Madzura T, Wollowitz A, Basset K, White D, Ruiz R, Sosnowski F, Nori P. Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City. Open Forum Infect Dis. 2021 Aug; 8(8):ofab313. PMID: 34458391.
      Citations: 1     
    5. Klassen SA, Senefeld JW, Senese KA, Johnson PW, Wiggins CC, Baker SE, van Helmond N, Bruno KA, Pirofski LA, Shoham S, Grossman BJ, Henderson JP, Wright RS, Fairweather D, Paneth NS, Carter RE, Casadevall A, Joyner MJ. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151. PMID: 34164419.
      Citations: 7     
    6. Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, Thompson MA, Baker SE, Nicholson WT, Johnson PW, Carter RE, Henderson JP, Hartman WR, Pirofski LA, Wright RS, Fairweather L, Bruno KA, Paneth NS, Casadevall A, Joyner MJ. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021 08; 61(8):2503-2511. PMID: 34036587.
      Citations: 9     Fields:    Translation:Humans
    7. Citations: 5     Fields:    Translation:HumansPHPublic Health
    8. Trogen B, Pirofski LA. Understanding vaccine hesitancy in COVID-19. Med (N Y). 2021 May 14; 2(5):498-501. PMID: 33851144.
      Citations: 3     
    9. Casadevall A, Henderson JP, Joyner MJ, Pirofski LA. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities. J Clin Invest. 2021 04 01; 131(7). PMID: 33621214.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    10. Casadevall A, Pirofski LA, Joyner MJ. The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19. mBio. 2021 03 02; 12(2). PMID: 33653885.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    11. Citations: 14     Fields:    Translation:Humans
    12. Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275. PMID: 33958057.
      Citations: 35     Fields:    Translation:Humans
    13. Casadevall A, Joyner MJ, Pirofski LA. Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. N Engl J Med. 2021 01 14; 384(2):189. PMID: 33378610.
      Citations: 5     Fields:    Translation:Humans
    14. Herrera NG, Morano NC, Celikgil A, Georgiev GI, Malonis RJ, Lee JH, Tong K, Vergnolle O, Massimi AB, Yen LY, Noble AJ, Kopylov M, Bonanno JB, Garrett-Thomson SC, Hayes DB, Bortz RH, Wirchnianski AS, Florez C, Laudermilch E, Haslwanter D, Fels JM, Dieterle ME, Jangra RK, Barnhill J, Mengotto A, Kimmel D, Daily JP, Pirofski LA, Chandran K, Brenowitz M, Garforth SJ, Eng ET, Lai JR, Almo SC. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis. ACS Omega. 2021 Jan 12; 6(1):85-102. PMID: 33458462.
      Citations: 19     
    15. Casadevall A, Grossman BJ, Henderson JP, Joyner MJ, Shoham S, Pirofski LA, Paneth N. The Assessment of Convalescent Plasma Efficacy against COVID-19. Med (N Y). 2020 Dec 18; 1(1):66-77. PMID: 33363284.
      Citations: 9     
    16. Casadevall A, Pirofski LA. In fatal COVID-19, the immune response can control the virus but kill the patient. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30009-30011. PMID: 33177233.
      Citations: 7     Fields:    Translation:HumansCells
    17. Casadevall A, Joyner MJ, Pirofski LA. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest. 2020 10 01; 130(10):5112-5114. PMID: 32634126.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    18. Punjabi CD, Madaline T, Gendlina I, Chen V, Nori P, Pirofski LA. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia. Infect Control Hosp Epidemiol. 2021 09; 42(9):1156-1158. PMID: 32843125.
      Citations: 3     Fields:    Translation:HumansCells
    19. Casadevall A, Joyner MJ, Pirofski LA. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. JAMA. 2020 08 04; 324(5):455-457. PMID: 32492105.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    20. Dieterle ME, Haslwanter D, Bortz RH, Wirchnianski AS, Lasso G, Vergnolle O, Abbasi SA, Fels JM, Laudermilch E, Florez C, Mengotto A, Kimmel D, Malonis RJ, Georgiev G, Quiroz J, Barnhill J, Pirofski LA, Daily JP, Dye JM, Lai JR, Herbert AS, Chandran K, Jangra RK. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition. Cell Host Microbe. 2020 09 09; 28(3):486-496.e6. PMID: 32738193.
      Citations: 53     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    21. Pirofski LA, Casadevall A. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework. mBio. 2020 07 02; 11(4). PMID: 32616514.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    22. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765. PMID: 32254064.
      Citations: 312     Fields:    Translation:HumansCellsPHPublic Health
    23. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 04 01; 130(4):1545-1548. PMID: 32167489.
      Citations: 352     Fields:    Translation:HumansCellsPHPublic Health
    Pirofski's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (151)
    Explore
    _
    Co-Authors (169)
    Explore
    _
    Similar People (60)
    Explore
    _